AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ClearPoint Neuro, Inc. Director's Dealing 2025

Jun 13, 2025

32641_dirs_2025-06-12_0d364acb-8645-42af-9fad-97e8d9cdc3bc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2025-06-10

Reporting Person: BURNETT JOSEPH (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-10	Common Stock	F	15476	$13.29	Disposed	9887	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	243522	Indirect

Footnotes

F1: Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

F2: These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.